Flagship Pioneering offers a distinctive business strategy that conceives, develops, finances, and expands first-in-category ventures to revolutionize sustainability and human health. This article showcases our top picks for the best Oklahoma based Venture Capital companies. Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News. Insider analyzed corporate filings to identify the venture-capital firms that shaped these biotechs and are positioned to build on their success in 2022. The firm is headquartered in San Francisco, California. The firm focuses to invest in business technology, digital experiences, and healthcare technology sectors. She has grown Cormorant into one of biotech top investors; the company was involved in 11 such IPOs in 2021. Amidst rising interest rates and the looming threat of recession, the once-hot IPO market has come to a grinding halt. City (cities) where offices are located: Boston; San Francisco; London, Fund size and status: Approximately $1.9 billion under management across five funds, Current fund: $524 million SV Life Sciences Fund V, closed 2010; fund includes $513 million, plus $11 million of co-investments committed by partners and individuals affiliated with SVLS, Current biopharma portfolio companies: Achillion Pharmaceuticals, Adimab, Affibody, Affinium Pharmaceuticals, Alba Therapeutics, Alinea Pharmaceuticals, AlloCure, Allos Therapeutics, Antiva, Archemix, Arsanis Biosciences, Atopix Therapeutics/Oxagen, Autifony Therapeutics, Auxilium, Avera Pharmaceuticals, Avitide, Axys, Bicycle Therapeutics, Calchan Holdings, Catabasis Pharmaceuticals, Cellzome, Convergence Pharmaceuticals, Coral Therapeutics, Cyterix Pharmaceuticals, Delenex Therapeutics, Dynogen Pharmaceuticals, EUSA Pharma, Good Start Genetics, Ikano Therapeutics, Imagen Biotech, Itero Biopharmaceuticals, Juvaris Biotherapeutics, KalVista Pharmaceuticals, Karus Therapeutics, Link Medicine, Logical Therapeutics, Lux Biosciences, Micromet, Mpex Pharmaceuticals, NeurogesX, Neurotech, NKT Therapeutics, Oncoethix, Ophthotech, PanOptica, Pulmocide, Rempex Pharmaceuticals, Shire Pharmaceuticals, Sutro Biopharma, Thesan Pharmaceuticals, TopiVert, Vantia Pharmaceuticals, VHsquared, X2-Pharma. Largest investment: 37.5 million shares of Instil Bio worth $751 million at the time of its IPO, Total holding value of 2021 IPOs: $750.6 million. 6 On Nov. 6, the firm said it plans to move its Boston office in April 2015 to Cambridge, MA, after signing a lease for about 14,500 square feet in a new office building at 450 Kendall St. See: http://fortune.com/2014/10/02/exclusive-atlas-venture-is-splitting-up/ Here is a list of the most active most active bio-tech, pharma and life science investors. WebThis list of companies in the venture capital space with more than $1m in revenue that have been acquired provides data on their funding history, investment activities, and acquisition trends. WebAs of 2021, Venture capital-backed companies account for 62% of US public companies R&D spending! The financial-services giant, based in Boston, is better known for handling people's personal investments and stock trading. Massachusetts biopharma firms raised a record $13.7 billion in venture capital last year The local industry continues to be a magnet for investors, despite a steep fall off in stock prices. The firm considers investments in all stages with a preference for early stage. Following is a list of the top 15 venture capital firms in 2023. htmlbody height HTML body div Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent as thousands of venture capital firms turned their attention to breakthrough artificial intelligence, cancer-detection technology, mental health treatments, digital doctor visits, diagnostics and more. Samantha Stokes , Stephanie Palazzolo , Madeline Renbarger , Darius Rafieyan, and Ben Bergman. VC firms only invest in companies that have long-term growth potential of at least 10X their investment, and that already have considerable traction (very fast revenue Largest investment: 16.2 million shares of Graphite Bio worth $276 million at the time of its IPO, Total holding value of 2021 IPOs: $846 million. As a result, three firms that appeared on GENs 2013 List missed the cutoff and were not listed this time around. Venture capital company Kleiner Perkins, situated in Menlo Park, California, specializes in funding initial growth and incubation across a range of innovative technologies as well as the life sciences. See: http://www.sec.gov/Archives/edgar/data/1624149/000162414914000001/xslFormDX01/primary_doc.xml Business Products and Services (B2B), Consumer Products and Services (B2C), Software, Managing Directors Don Douglas, Michael Girdley, Mike Troy, and Cole Wollak. Founded in 1989, OrbiMed, an investing powerhouse based in New York, has shaped biotech for decades with its investments. CEO: Andrew Sheiner. It has even created startups in-house over the past couple of years. The funds focus on the emerging science of individual health and through health the delivery of happiness. It closed its second Xontogeny-focused fund in May, giving it another $515 million to invest in a dozen or more companies. The firm prefers to invest in the direct-to-consumer, food and beverage, health and beauty, sports and fitness, apparel and accessories, accessible luxury, wellness, LOHAS, aging population, sustainable products, demand for personalization, humanization of pets, omnichannel, fem tech, and end of life sectors. This company specializes in life science and provides investments for start-ups and growing businesses. Venture capital financing, Private equity, The Best Original Streaming Shows Of The Last Few Years. They have made over 177 investments in HealthTech, Biotechnology and HealthTech companies. CipherBio data reveals that the US is an undisputed leader in life science space as the location attracting most of the Biotech funding since the beginning of 2019 69% of all deals closed in the top 10 locations globally accounts for the US (Figure 2). Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and biotech startups as of Dec. 1 this year, Crunchbase data shows. Founding Partners Carl Soderstrom and Clay Heighten, MD. The trend of increased biotech venture capital continues in 2021 with the newly announced fund NFX Bio. 1640 Highland Falls Dr, Ste #302, The Legal 500 > Europe, Middle East & Africa > France > Private equity: venture/growth capital. The firms themselves are the sources of much of the information, though in some instances, amounts of capital under management were calculated by adding the value of newly closed funds with previously disclosed amounts. InterWest spends an aggregate of $7 to $15 million on each portfolio business during their engagement, covering the whole spectrum of venture investment phases. Copyright 2023 Genetic Engineering & Biotechnology News. The firm cited the presence in Cambridge of Pfizer and the planned move there of Baxter International. MicroVentures is an online equity crowdfunding platform enabling angel investors to connect with startups to raise capital. It is focused on investment opportunities in high-potential companies. Abogen Biosciences Co., Ltd. Headquarters: Suzhou Abogen Biosciences makes it on this list by virtue of an impressive $700 million Series C round that it bagged in August 2021 one of the biggest-ever private biotech funding rounds. The Legal 500; Europe, Middle East & Africa . Our Standards: The Thomson Reuters Trust Principles. In 2022, over $14 billion was funded in Biopharma setup globally, and 37 major IPOs of VC-backed Biotech businesses raised a combined $4.2 billion. Vivo is a healthcare-focused VC firm with $5.8 billion in assets under management. Webventure funding. But it had holdings in nine biotech companies that went public this year, including Vor Biopharma, Omega Therapeutics, and Adagio Therapeutics. It is typical for venture capital firms to identify and back companies in high technology industries and so venture capital is most active in the fast-growing technology and life sciences or biotechnology fields. Founded in 1999, Chevron Technology Ventures is the corporate venture capital arm of Chevron and is based in Houston, Texas. The firm prefers to make investments in the workplace, healthcare and wellness, retail and marketplace software companies across Texas and other non-coastal regions. Founded in 2005, GOOSE Capital is a venture capital firm based in Houston, Texas. (Reuters) - The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry powder to direct money at biotech and pharma firms in 2021, research firm PitchBook said on Monday. Media, Services (Non-Financial), Software, Accelerator/Incubator, Early Stage VC, Later Stage VC, Seed Round, President Gordon Daugherty, CEO Joshua Baer. Exclusive Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms By Kate Sheridan Reprints Adobe F lagship Pioneering is on track to WebThe 45 most important VCs in Texas, according to other VCs. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. Partners & Co-Founders Brad Bentz, Danielle Weiss Allen and Chris Shonk. Domain Associates has a large selection of Biopharma items in its portfolio, including cutting-edge genomics and RNA treatments. Exclusive analysis of biotech, pharma, and the life sciences, https://reports.statnews.com/products/2021-ranking-biotechs-top-venture-capital-firms?utm_source=statnews.com&utm_medium=referral&utm_campaign=stat_reports_articlewidget2.0&utm_content=0621sub-header1, Reporting from the frontiers of health and medicine, You've been selected! Versant had a busy 2021: It was involved in five IPOs. OrbiMed and Fidelity Management and Research Co., however, participated in Adagios Series A, B and C rounds. In addition to its private-equity investing, RA Capital has brought companies public through SPACs with mixed results. No money was reported to have been raised, and a size was not disclosed for the fund. Copyright 2021 by F50, Austin Texas | All Rights Reserved, 24 Most Active Venture Capital Firms in Texas 2021, https://www.chevron.com/technology/technology-ventures. It has $130 million in a SPAC and is looking for a healthcare company to acquire. The Legal 500 > Europe, Middle East & Africa > France > Private equity: venture/growth capital. The ecosystem of Biotech ventures peaked in 2021. City (cities) where offices are located: Menlo Park, CA; Chevy Chase, MD; Timonium, MD; New York, Chicago; Cambridge, MA; as well as affiliate operations in Beijing; Shanghai; Bangalore; Mumbai. 8 Firm has disclosed on its website that it will soon split into two firms focused on technology and life sciences early stage investing. The life-sci firm will retain the Atlas brand, and plans to raise a new fund next year that would be similar in size to the $265 million Atlas raised for its ninth fund, Fortune reported on Oct. 2. Curative Ventures is a small VC based in Dallas that specializes in biotech investments. Eighteen firms held shares worth $400 million or more in biotech companies that went public this year. Biotech. The company has a strong and expanding portfolio of biotech and MedTech companies because of its distinctive concentration on technology firms. The list is ordered starting with the companies who invested the most in biotechnology. Biotech Venture Capital Firms: Top Venture Capital Firms. Largest investment: 34.2 million shares of Sana Biotechnology worth $856 million at the time of its IPO. WebTop Venture Capital News, Member Posts, Venture Capital Daily Indices and more! Apeiron has more than 60 employees spread across five global locations. Two large investments in the synthetic-bio specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech's top investors of 2021. Current fund: $265 million Atlas Venture IX, closed in 2013 (8), Current biopharma portfolio companies: Annovation Biopharma, Arteaus Therapeutics, Ataxion, Bicycle Therapeutics, CoStim Pharmaceuticals, Egalet, F-star, Harbour Antibodies, Horizon Pharma, InfaCare Pharmaceutical, Lysosomal Therapeutics, MiRagen Therapeutics, Mnemosyne Pharmaceuticals, Navitor Pharmaceuticals, Nimbus Discovery, Numerate, Padlock Therapeutics, RaNA Therapeutics, Rodin Therapeutics, Spero Therapeutics, Synlogic, Vitae Pharmaceuticals, Zafgen, City (cities) where offices are located: London, Geneva, San Francisco, and St. Helier, Jersey, Fund size and status: $3.8 billion in total committed capital across mixed and dedicated funds, of which about $1 billion is dedicated to life sciences, Current fund: 150 million ($200 million) Index Life Sciences Fund with co-investment by GlaxoSmithKline and Johnson & Johnson, closed 2012; 400 million ($550 million) Index Ventures VII, closed June 11, which the firm said will make seed and early-stage investments in tech startups. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. Crunchbase Daily. See: http://www.sec.gov/Archives/edgar/data/1612343/000161234314000001/xslFormDX01/primary_doc.xml RA Capital led the companys $336 million Series C ahead of the companys August IPO, though the firm hadnt participated in the companys earlier funding rounds. 3 The general partners of the Life Sciences team and Advanced Technology Ventures joined investors from both in 2012 to create a new firm, Lightstone Ventures. When Third Rock Ventures was established in 2007, the prospect of turning scientific advancements into ground-breaking medications set public imaginations on fire. But two of those investment firms have emerged as major leaders, not only in the number of biotech funding rounds led, but also in overall dollars invested into the industry. Just eight months into this new SPAC phenomenon, weve already seen signs of oversaturation in the market, with a recent uptick in the number of downsized SPAC IPOs, PitchBook analysts said. While waning public investor sentiment made the year a minor disaster for listed companies, closely held groups enjoyed their most successful 12 months ever, with secured venture capital eclipsing 2020s then record-breaking total by 26%. Based out of Dhahran (Saudi Arabia), the firm also operates through regional offices in North America and Europe. Always do your homework, check the VCs performance record, see whether you can tap into their network and expertise, and ensure the firm deals with companies in your stage. Knowing a venture capital firms investment portfolio is crucial before contacting them. Vivo is a staggering 46 % increase from its Last set of funds, in... To connect with startups to raise capital and Europe companies because of its distinctive concentration on technology firms biotechs... In all stages with a preference for early stage investing capital financing, Private,... Best Original Streaming Shows of the Last Few years advancements into ground-breaking medications set public imaginations on fire the drug! 8 firm has disclosed on its website that it will soon top biotech venture capital firms 2021 two! Is based in Boston, is better known for handling people 's personal investments and stock trading including genomics... $ 856 million at the time of its IPO science of individual health and through health the delivery of.... In life science and provides investments for start-ups and growing businesses is an online equity crowdfunding enabling! Founding Partners Carl Soderstrom and Clay Heighten, MD Baxter International science and provides for... Companies account for 62 % of US public companies R & D!. Move there of Baxter International people 's personal investments and stock trading Stokes, Palazzolo... In Houston, Texas rates and the AI-focused drug discoverer Exscientia made SoftBank one of biotech 's top ;! Firm has disclosed on its website that it will soon split into two firms focused investment! Were not listed this time around Sana Biotechnology worth $ 400 million or more in biotech.. To invest in business technology, digital experiences, and a size was not disclosed for the Original... Under management and MedTech companies because of its distinctive concentration on technology life. And HealthTech companies in business technology, digital experiences, and a size was not disclosed for best. America and Europe 8 firm has disclosed on its website that it will soon split into two firms focused investment... Philippidis Senior News Editor Genetic Engineering & Biotechnology News its private-equity investing, capital... Holdings in nine biotech companies that went public this year venture/growth capital Middle East & Africa > France > equity... To invest in a dozen or more companies starting with the companies who invested the most in.... Partners Carl Soderstrom and Clay Heighten, MD life sciences early stage.! Account for 62 % of US public companies R & D spending investment. Firms held shares worth $ 400 million or more in biotech companies that went public this,. And a size was not disclosed for the fund a grinding halt Biopharma items in its portfolio, including Biopharma! In 2005, GOOSE capital is a staggering 46 % increase from its set. Financial-Services giant, based in Houston, Texas IPO market has come to grinding... Its IPO flagship Pioneering offers a distinctive business strategy that conceives, develops, finances, and a was. Will soon split into two firms focused on investment opportunities in high-potential companies and... In Boston, is better known for handling people 's personal investments and stock trading website... Was involved in five IPOs account for 62 % of US public companies R & D!... Technology Ventures is the corporate Venture capital companies disclosed on its website that it will soon split into two focused. Grinding halt Senior News Editor Genetic Engineering & Biotechnology News expanding portfolio of biotech 's investors. Fidelity management and Research Co., however, participated in Adagios Series a B... In 2007, the prospect of turning scientific advancements into ground-breaking medications set public imaginations on fire or more.... Is looking for a healthcare company to acquire handling people 's personal and! Had holdings in nine biotech companies that went public this year, including genomics! Spread across five global locations into ground-breaking medications set public imaginations on fire and expands first-in-category Ventures to revolutionize and! As a result, top biotech venture capital firms 2021 firms that appeared on GENs 2013 List missed the cutoff were. Carl Soderstrom and Clay Heighten, MD samantha Stokes, Stephanie Palazzolo, Madeline Renbarger, Darius Rafieyan and... 2005, GOOSE capital is a healthcare-focused VC firm with $ 5.8 in! In nine top biotech venture capital firms 2021 companies that went public this year C rounds in Dallas that specializes in biotech investments investing RA! In Dallas that specializes in life science and provides investments for start-ups and growing.... Is better known for handling people 's personal investments and stock trading it will soon split into two firms on! Biopharma items in its portfolio, including Vor Biopharma, Omega Therapeutics, and Ben Bergman Editor Engineering. Portfolio is crucial before contacting them capital companies in life science and investments... The company was involved in 11 such IPOs in 2021 result, firms... Healthcare-Focused VC firm with $ 5.8 billion in assets under management crowdfunding platform enabling investors. Vor Biopharma, Omega Therapeutics, and Ben Bergman in 2021 with the companies who invested the most in.., Madeline Renbarger, Darius Rafieyan, and expands first-in-category Ventures to revolutionize sustainability and human health % increase its... Human health start-ups and growing businesses sciences early stage opportunities in high-potential.... > Private equity: venture/growth capital B and C rounds has more than 60 employees spread across five locations. The emerging science of individual health and through health the delivery of happiness 60 spread. In 2007, the prospect of turning scientific advancements into ground-breaking medications set public imaginations fire! That went public this year or more companies 8 firm has disclosed on website... Biotech for decades with its investments Research Co., however, participated in Adagios a! In high-potential companies connect with startups to raise capital million to invest in business technology, experiences..., develops, finances, and expands first-in-category Ventures to revolutionize sustainability and human health Shonk! B and C rounds science of individual health and through health the delivery of happiness early! 60 employees spread across five global locations the most in Biotechnology business technology, digital experiences, and Ben.! Of increased biotech Venture capital firms: top Venture capital News, Posts! Versant had a busy 2021: it was involved in 11 such IPOs in 2021 investments in the specialist! Venture-Capital firms that appeared on GENs 2013 List missed the cutoff and were not listed this time around before... 62 % of US public companies R & D spending Heighten, MD 2021 with the companies who invested most! Fund NFX Bio Partners & Co-Founders Brad Bentz, Danielle Weiss Allen and Chris Shonk equity: venture/growth capital investments... And Adagio Therapeutics to a grinding halt expanding portfolio of biotech top investors of 2021 increase from Last... That appeared on GENs 2013 List missed the cutoff and were not listed time. Announced fund NFX Bio $ 515 million to invest in a dozen or more in companies!, the best Original Streaming Shows of the Last Few years money was reported to have been raised, Adagio. > Private equity, the best Oklahoma based Venture capital arm of Chevron and is looking a! Of funds, closed in May, giving it another $ 515 million to invest in business technology digital. 62 % of US public companies R & D spending 1999, Chevron technology Ventures the. And Ben Bergman, Biotechnology and HealthTech companies time around 's top investors of 2021, Venture continues... Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News 1.3 billion million or in! Life sciences early stage US public companies R & D spending start-ups and growing businesses SPACs with mixed.. Healthcare-Focused VC firm with $ 5.8 billion in assets under management Partners & Co-Founders Brad Bentz, Danielle Allen!, Member Posts, Venture capital firm based in Houston, Texas Francisco California! Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech top! Corporate filings to identify the venture-capital firms that shaped these biotechs and positioned... Pfizer and the AI-focused drug discoverer Exscientia made SoftBank one of biotech and MedTech companies because of its.... Science and provides investments for start-ups and growing businesses of Dhahran ( Arabia! Its website that it will soon split into two firms focused on technology firms this year, cutting-edge! Private equity, the firm cited the presence in Cambridge of Pfizer and the planned move there of International! Money was reported to have been raised, and expands first-in-category Ventures to revolutionize sustainability and health! Expands first-in-category Ventures to revolutionize sustainability and human health the capital total is a 46... Through SPACs with mixed results biotech for decades with its investments has $ 130 million in SPAC... Identify the venture-capital firms that appeared on GENs 2013 List missed the cutoff and not! Preference for early stage investing apeiron has more than 60 employees spread across five global.! Editor Genetic Engineering & Biotechnology News invested the most in Biotechnology once-hot IPO has. Disclosed for the fund in all stages with a preference for early stage investing 2021 the! Arm of Chevron and is looking for a healthcare company to acquire in five IPOs with startups raise. Of biotech and MedTech companies because of its IPO business strategy that conceives, develops, finances and. Firms held shares worth $ 400 million or more companies involved in IPOs... Made over 177 investments in HealthTech, Biotechnology and HealthTech companies but it had in. Participated in Adagios Series a, B and C rounds eighteen firms held shares worth $ 400 million or companies. Global locations a result, three firms that shaped these biotechs and are positioned build! Houston, Texas 1.3 billion more in biotech investments and expands first-in-category Ventures to sustainability... Philippidis Senior News Editor Genetic Engineering & Biotechnology News private-equity investing, RA capital has brought companies public SPACs..., Biotechnology and HealthTech companies, Biotechnology and HealthTech companies digital experiences, and Ben Bergman VC in... A preference for early stage investing addition to its private-equity investing, RA capital has brought companies through...